Avastin Improves Survival By 30 Percent In Advanced Non-Small Cell Lung Cancer
Oxaliplatin Added To 5-FU/LV Improves Disease-Free Survival In Early Colon Cancer
Irinotecan And Carboplatin Improve Response In NSCLC
Enzastaurin Shows Activity In Recurrent High-Grade Glioma
Calcitrol+Docetaxel Prolongs Survival In Prostate Cancer
Gemcitabine Improves DFS In Resected Pancreatic Cancer
Rosenberg: Immunotherapy May Have Broad Potential
NCI-Approved Clinical Trials
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
- One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
- Vinay Prasad, oncology’s gadfly-turned-CBER-director, will leave FDA (again)
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - As more people are surviving cancer, we must continue funding bold science









